This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ecancer
J

ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"

By ecancer FEATURING Jane Meisel
By ecancer FEATURING Jane Meisel
235 views
June 20, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

2024 ASCO® Annual Meeting Insights Hub: Breast Videos

24:36

ASCO 2024 Highlights: Insights From Key Abstracts on mBC

2024 ASCO® Annual Meeting Insights Hub

S. Aithal

178 views
09:34

ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care …

2024 ASCO® Annual Meeting Insights Hub

M. Lipsyc-Sharf

303 views
05:06

ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Br…

2024 ASCO® Annual Meeting Insights Hub

M. Bhave

463 views
View All

Related Videos

25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

4.2K views
09:55

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.5K views
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

772 views
05:43

Neoadjuvant Chemo for HR+ BC: Year in Review

Total Health

C. Ma

977 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

921 views
22:34

What's New in Breast Cancer?

Dana-Farber Cancer Institute

S. Tolaney

1.6K views
10:34

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

932 views
21:31

ESMO Breast 2024 Summary: "Community Oncologists Highlights"

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney, H. Rugo

1.1K views
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

619 views
06:10

ESMO Breast 2024 Summary: "Is There a Role for Combining ADCs With t…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

844 views
15:57

New

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

464 views
10:09

ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatment Aft…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

656 views
07:50

ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, & Toler…

Oncology Data Advisor

K. Kalinsky

1.0K views
13:47

HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sen…

Stanford Medicine

M. Dolezal

1.1K views
12:55

Advances in Targeted and Endocrine Therapies for Metastatic HR+/HER2…

UChicago Medicine

N. Chen

520 views
17:35

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HER2CLIMB-0…

Insights from 2023 SABCS

P. Tarantino

1.1K views
05:35

ESMO Breast 2024 Insights: "IMpassion132 Trial - Is There a Role for…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

524 views
09:54

Adjuvant Abemaciclib + Endocrine Therapy for HR+, HER2- High-Risk eB…

Insights from 2023 ESMO Annual Meeting

J. Huober

1.5K views
AUTOPLAY